Immunotherapy of Advanced Cancer

Charles G. Moertel, Richard Nora, Chandra Belani, Henry Silverman, Jeffrey Abrams, William H. West, Kurt W. Tauer, Robert K. Oldham, Douglas W. Orr, John Yannelli, Elizabeth Ann Grimm, Steven A. Rosenberg

Research output: Contribution to journalLetter

10 Scopus citations

Abstract

To the Editor: The report of Rosenberg and associates (Dec. 5, 1985, issue)1 describing their experience with adoptive immunotherapy of advanced cancer is certainly of scientific interest. The presentation of this study by the public media, however, has generated unrealistic expectations among patients with advanced cancer and their families, as evidenced by the thousands of calls pouring in to physicians and cancer centers. Out of concern for these patients, I hope that the investigators will join me in the following realistic appraisal of their results. (1) There is no evidence that this therapy will cure human cancer. (2) There is…

Original languageEnglish (US)
Pages (from-to)274-276
Number of pages3
JournalNew England Journal of Medicine
Volume316
Issue number5
DOIs
StatePublished - Jan 29 1987

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Immunotherapy of Advanced Cancer'. Together they form a unique fingerprint.

  • Cite this

    Moertel, C. G., Nora, R., Belani, C., Silverman, H., Abrams, J., West, W. H., Tauer, K. W., Oldham, R. K., Orr, D. W., Yannelli, J., Grimm, E. A., & Rosenberg, S. A. (1987). Immunotherapy of Advanced Cancer. New England Journal of Medicine, 316(5), 274-276. https://doi.org/10.1056/NEJM198701293160513